Inicio/Acciones/PLSE

PLSE

USD

Pulse Biosciences Inc Common Stock (DE)

$16.060-0.440 (-2.667%)

Precio en Tiempo Real

Healthcare

Medical Instruments & Supplies

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$16.500

Máximo

$16.770

Mínimo

$15.800

Volumen

0.11M

Fundamentos de la Empresa

Capitalización de Mercado

1.1B

Industria

Medical Instruments & Supplies

País

United States

Estadísticas de Negociación

Volumen Promedio

0.18M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $13.766Actual $16.060Máximo $25

Noticias Relacionadas

24 oct 2025 · 11:00

BusinessWire

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

First U.S. Surgical Treatments with PFA Clamp for Patients with Atrial Fibrillation During Concomitant Surgical Procedure Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

22 oct 2025 · 20:05

BusinessWire

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

10 oct 2025 · 11:00

BusinessWire

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Successfully treated atrial fibrillation (AF) in initial 30 patients with the nPulse™ Cardiac Surgical System Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology